<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Barrett's mucosa is the precursor of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>The molecular mechanisms behind Barrett's <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> are largely unknown </plain></SENT>
<SENT sid="2" pm="."><plain>Experimental models of longstanding <z:e sem="disease" ids="C0017168,C0559234" disease_type="Disease or Syndrome;Finding" abbrv="">esophageal reflux</z:e> of duodenal-gastric contents may provide important information on the biological sequence of the Barrett's <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">oncogenesis</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: The expression of CDX2 <z:chebi fb="0" ids="46904">hox</z:chebi>-gene product was assessed in a rat model of Barrett's <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Seventy-four rats underwent esophago-jejunostomy with gastric preservation </plain></SENT>
<SENT sid="5" pm="."><plain>Excluding perisurgical <z:hpo ids='HP_0011420'>deaths</z:hpo>, the animals were sacrificed at various times after the surgical treatment (Group A: &lt;10 weeks; Group B: 10-30 weeks; Group C: &gt;30 weeks) </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: No Cdx2 expression was detected in either squamous epithelia of the proximal esophagus or <z:hpo ids='HP_0002860'>squamous cell carcinomas</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>De novo Cdx2 expression was consistently documented in the proliferative zone of the squamous epithelium close to reflux <z:mpath ids='MPATH_579'>ulcers</z:mpath> (Group A: 68%; Group B: 64%; Group C: 80%), multilayered epithelium and <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> (Group A: 9%; Group B: 41%; Group C: 60%), and esophageal <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> (Group B: 36%; Group C: 35%) </plain></SENT>
<SENT sid="8" pm="."><plain>A trend for increasing overall Cdx2 expression was documented during the course of the experiment (p = 0.001) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: De novo expression of Cdx2 is an early event in the spectrum of the lesions induced by experimental <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">gastro-esophageal reflux</z:e> and should be considered as a key step in the morphogenesis of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
</text></document>